as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
0.12%
Downside
1.32%
Upside
52 Week's Low
52 Week's High
21.26%
Downside
8.29%
Upside
Check Gsk Plc-spon Adr. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$82.7B
EPS (TTM)
4.1367
Dividend Yield
3.45%
Quarterly Earnings Growth YOY
0.23%
PE Ratio (TTM)
18.23
Industry PE ratio
16.328333333333333
P/B Ratio
18.2277
PEG Ratio
0.3545
EBITDA
9.3B
Revenue (TTM)
31.6B
Profit Margin
10.82%
Return On Equity TTM
28.33%
Track how Gsk Plc-spon Adr. P/E has moved over time to understand its valuation trends.
Gsk Plc-spon Adr. in the last 5 years
Lowest (8.77x)
March 31, 2025
Industry (16.33x)
September 15, 2025
Today (18.23x)
September 15, 2025
Highest (13.53x)
June 30, 2022
Today’s Price to Earnings Ratio: 18.23x
Compare market cap, revenue, PE, and other key metrics of Gsk Plc-spon Adr. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $82.7B | -16.82% | 18.23 | 10.82% | |
BUY | $677.2B | 403.32% | 49.28 | 25.91% | |
BUY | $385.7B | 140.17% | 103.97 | 6.45% | |
BUY | $240.9B | 61.57% | 14.03 | 35.61% | |
BUY | $428.8B | 19.59% | 19.04 | 25.00% |
The Gsk Plc-spon Adr. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Gsk Plc-spon Adr. investment value today
Current value as on today
₹98,638
Returns
Returns from Gsk Plc-spon Adr. Stock
Dollar Returns*
₹4,985 (+4.99%)
Based on 33 analysts
60.61%
Buy
30.30%
Hold
9.09%
Sell
Based on 33 analysts, 60.61% of analysts recommend a 'BUY' rating for Gsk Plc-spon Adr.. Average target price of $39.03
Get share price movements and forecasts by analysts on Gsk Plc-spon Adr..
What analysts predicted
-3.2%DOWNSIDE
Target Price
$39.03
Current Price
$40.28
Analyzed by
33 Analysts
Target
$39.03
Gsk Plc-spon Adr. target price $39.03, a slight downside of -3.2% compared to current price of $40.28. According to 33 analysts rating.
Search interest for Gsk Plc-spon Adr. Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 11 September
Thu, 09:00 PM
-GSK reports Q2 2025 revenues of $10.67 billion, up 7.2% year-over-year, with EPS of $1.23.
Thu, 10:11 PM
-GSK announces Phase 1 study on bepirovirsen for Hepatitis B treatment, potentially impacting stock performance positively.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
GSK Plc's revenue has shown positive growth over the last two quarters. It increased from $7.51 billion to $7.98 billion, representing an average growth of 5.9% per quarter.
Against Peers
In the last 3 years, Eli Lilly And Company has given 51.1% return, outperforming this stock by 20.4%
Against Peers
In the last 1 year, Abbvie Inc has given 11.2% return, outperforming this stock by 18.7%
Profit Down
GSK Plc's stock performance shows a declining trend in net profit over the last two quarters, with profits decreasing from $1.62 billion to $1.44 billion. This represents an average decrease of 11.2% per quarter.
Price Dip
In the last 7 days, GSK stock has moved down by -1.2%
Organisation | Gsk Plc-spon Adr. |
Headquarters | 79 New Oxford Street, London, United Kingdom, WC1A 1DG |
Industry | Health Technology |
CEO | Ms. Emma Natasha Walmsley |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Tony Wood | Chief Scientific Officer and Head of R&D |
Mr. Constantin Fest | Senior VP & Head of Investor Relations |
Mr. James Ford | Senior VP & Group General Counsel of Legal & Compliance |
Mr. David Simon Redfern BSc (Hons), CA | President of Corporate Development |
Ms. Diana Conrad | Chief People Officer |
Ms. Emma Natasha Walmsley | CEO & Director |
Ms. Shobie Ramakrishnan | Chief Digital & Technology Officer |
Ms. Sally Jackson | Senior VP of Global Communications & CEO Office |
Ms. Julie Belita Brown A.C.A. | CFO & Executive Director |
Dr. Jesse L. Goodman M.D., M.P.H. | Scientific & Medical Expert |
Gsk Plc-spon Adr. share price today is $40.28 as on at the close of the market. Gsk Plc-spon Adr. share today touched a day high of $40.81 and a low of $40.23.
Gsk Plc-spon Adr. share touched a 52 week high of $43.62 on and a 52 week low of $31.72 on . Gsk Plc-spon Adr. stock price today i.e. is closed at $40.28,which is 7.66% down from its 52 week high and 27.01% up from its 52 week low.
Gsk Plc-spon Adr. market capitalisation is $0.08T as on .
Indian investors can start investing in Gsk Plc-spon Adr. (GSK) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Gsk Plc-spon Adr. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Gsk Plc-spon Adr. share’s latest price of $40.28 as on September 16, 2025 at 1:29 am IST, you will get 0.2483 shares of Gsk Plc-spon Adr.. Learn more about
fractional shares .
Gsk Plc-spon Adr. stock has given -16.82% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?